|
|
07 Mar 2011
TWO FEMALE finance big-hitters have joined the board of GlaxoSmithKline (GSK) as non-executives.
Stacey Cartwright, CFO of Burberry (pictured), joins GSK's audit and risk committee. Also joining is Judy Lewent, CFO of healthcare business Merck & Co.
Further reading
"Their experience of global business and finance, and their respective knowledge of the pharmaceutical industry and consumer brands, will bring a fresh, external perspective to the board," said Sir Christopher Gent, GSK chairman.
Cartwright joined Burberry as CFO in 2003, and was appointed executive VP, CFO, in June 2008. She previously served as CFO for Egg between 1999 and 2003. Between 1988 and 1999 she worked in finance roles at Granada Group.
You may also like
Search thousands of financial jobs:
Search thousands of financial jobs:
Careers
Search for jobs
Click to search our database of all the latest accountancy roles
Create a profile
Click to set up your profile and let the best recruiters find you
Jobs by email
Sign up to receive regular updates with the latest roles suitable for you
Briefings
By looking at the reasons supplier statements became unfashionable, and the reasons why it is different today, this paper delves into the many benefits that can be obtained by automating the process.
Having a real and true view of your organisation’s current financial position, and having the right systems and processes in place, will ensure that you can make strong choices and are ready to capitalise on opportunities
AccountancyAgeInsight is a frequently updated resource centre for finance professionals, offering a free and easy-to-use digital library of briefings, white papers and other information resources. 
Visitor comments Add your comment